Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT Stock Forecast

Stock Price Forecast

The 8 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Hold" and an average price target of $20.75, which forecasts a 11.92% increase in the stock price over the next year. The lowest target is $20 and the highest is $22.

Price Target: $20.75 (+11.92%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$20	$20.75	$21	$22
Change	+7.87%	+11.92%	+13.27%	+18.66%

Analyst Ratings

The average analyst rating for Sabra Health Care REIT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	0	0	0	0	0
Buy	3	3	3	3	3	3
Hold	4	5	6	6	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	9	9	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $20 → $21	Hold	Maintains	$20 → $21	+13.27%	Jan 20, 2026
John Kilichowski Wells Fargo	Wells Fargo	Buy Maintains $20 → $21	Buy	Maintains	$20 → $21	+13.27%	Nov 25, 2025
Michael Goldsmith UBS	UBS	Hold Initiates $20	Hold	Initiates	$20	+7.87%	Nov 18, 2025
John Kilichowski Wells Fargo	Wells Fargo	Buy Maintains $21 → $20	Buy	Maintains	$21 → $20	+7.87%	Oct 21, 2025
Richard Anderson Cantor Fitzgerald	Cantor Fitzgerald	Hold Initiates $20	Hold	Initiates	$20	+7.87%	Oct 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

745.69M

Increased by 6.13%

from 702.64M

Revenue Next Year

788.24M

Increased by 5.71%

from 745.69M

EPS This Year

0.75

Increased by 39.51%

from 0.54

EPS Next Year

0.78

Increased by 3.87%

from 0.75

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	600.82M	388.24M	531.95M	644.62M	702.64M	745.69M	788.24M
Revenue Growth	-10.08%	-35.38%	37.02%	21.18%	9.00%	6.13%	5.71%
EPS	0.67	-0.52	-0.34	0.06	0.54	0.75	0.78
EPS Growth	81.76%	-	-	-	807.61%	39.51%	3.87%
Forward PE	-	-	-	-	-	24.61	23.69
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	808.0M	917.9M
Avg	745.7M	788.2M
Low	692.7M	550.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	15.0%	23.1%
Avg	6.1%	5.7%
Low	-1.4%	-26.2%

EPS Forecast

EPS	2025	2026	2027
High	0.85	0.88
Avg	0.75	0.78
Low	0.68	0.72

EPS Growth

EPS Growth	2025	2026	2027
High	57.5%	17.1%
Avg	39.5%	3.9%
Low	25.2%	-5.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.